KOLANTICON GEL Per Cent Oral Suspension आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

kolanticon gel per cent oral suspension

peckforton pharmaceuticals ltd - dicyclomine hydrochloride aluminium hydroxide gel magnesium oxidum leve dimeticone, activated - oral suspension - per cent

Midazolam 5 mg/ml Solution for injection or infusion आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

midazolam 5 mg/ml solution for injection or infusion

martindale pharmaceuticals ltd - midazolam hydrochloride - solution for injection/infusion - 5 milligram(s)/millilitre - benzodiazepine derivatives; midazolam

Orfenal 50mg coated Tablets माल्टा - अंग्रेज़ी - Medicines Authority

orfenal 50mg coated tablets

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - orphenadrine hydrochloride - coated tablet - orphenadrine hydrochloride 50 mg - anti-parkinson drugs

Ranitidine Relief न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

ranitidine relief

viatris limited - ranitidine hydrochloride 167.5mg equivalent to ranitidine 150 mg - film coated tablet - 150 mg - active: ranitidine hydrochloride 167.5mg equivalent to ranitidine 150 mg excipient: castor oil colloidal silicon dioxide croscarmellose sodium hypromellose e-15 iron oxide yellow isopropyl alcohol magnesium stearate microcrystalline cellulose purified talc purified water titanium dioxide - symptomatic relief of heartburn, dyspepsia and hyperacidity in adults and children over 12 years.

RANITIDINE tablet संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

ranitidine tablet

state of florida doh central pharmacy - ranitidine (unii: 884kt10yb7) (ranitidine - unii:884kt10yb7) - ranitidine 150 mg - ranitidine tablets are indicated in: - short-term treatment of active duodenal ulcer. most patients heal within 4 weeks. studies available to date have not assessed the safety of ranitidine in uncomplicated duodenal ulcer for periods of more than 8 weeks. - maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers. no placebo-controlled comparative studies have been carried out for periods of longer than 1 year. - the treatment of pathological hypersecretory conditions (e.g., zollinger-ellison syndrome and systemic mastocytosis). - short-term treatment of active, benign gastric ulcer. most patients heal within 6 weeks and the usefulness of further treatment has not been demonstrated. studies available to date have not assessed the safety of ranitidine in uncomplicated, benign gastric ulcer for periods of more than 6 weeks. - maintenance therapy for gastric ulcer patients at reduced dosage after healing of acute ulcers. placebo-controlled studies have been carried out for

ZANTAC ranitidine hydrochloride injection solution संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

zantac ranitidine hydrochloride injection solution

cardinal health - ranitidine hydrochloride (unii: bk76465ihm) (ranitidine - unii:884kt10yb7) - ranitidine 25 mg in 1 ml